Stankov, Karmen
Type
Fulltext
Results 1-20 of 23 (Search time: 0.003 seconds).
| Issue Date | Title | Author(s) | |
|---|---|---|---|
| 1 | 2018 | 12-oxo chenodeoxycholic acid potentiates doxorubicin-induced oxidative stress through Nrf2 axis in breast adenocarcinoma cells | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Jasmina Katanić ; Iva Barjaktarović ; Momir Mikov |
| 2 | 2017 | Antioxidant effects of ursodeoxycholic acid in doxorubicin-induced oxidative hepatocyte injury | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Svetlana Goločorbin-Kon ; Velibor Vasović ; Momir Mikov |
| 3 | 1-Aug-2013 | The bile acid membrane receptor TGR5: A novel pharmacological target in metabolic, inflammatory and neoplastic disorders | Vanesa Stepanov ; Karmen Stankov ; Momir Mikov |
| 4 | 2018 | Bile acid potentiates apoptosis of human breast adenocarcinoma cells induced by doxorubicin | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Bogdanović G; Vesna Kojić ; Momir Mikov |
| 5 | 1-Feb-2015 | Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases | Stanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir |
| 6 | 8-Nov-2018 | Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Maja Đanić ; Bojan Stanimirov ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
| 7 | 1-Jan-2014 | C-KIT signaling in cancer treatment | Stankov, Karmen ; Popović, Živko; Mikov, Momir |
| 8 | 1-Jan-2019 | DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment | Mikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan ; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Al-Salami H. |
| 9 | 1-Jan-2012 | Effect of simultaneous exposure to benzene and ethanol on urinary thioether excretion | Ivan Mikov ; Karmen Stankov ; Velibor Vasović ; Aleksandra Mikov ; Svetlana Goločorbin-Kon ; Momir Mikov |
| 10 | 2016 | The effects of usodeoxycholic acid on cytotoxic activity and proapoptotic potential of doxorubicin in MCF-7 cell line | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Vesna Kojić ; Iva Barjaktarović ; Momir Mikov |
| 11 | 1-Apr-2012 | Ethical and legal aspects of oncogenomics | Stankov, Karmen ; Drašković, Dragan ; Mikov, Momir |
| 12 | 1-Jan-2012 | The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease | Stojancevic M.; Stankov, Karmen ; Mikov, Momir |
| 13 | 2019 | In silico alternatives to animal testing: state of the art | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Maja Đanić ; Bojan Stanimirov ; Mladena Lalić-Popović ; Momir Mikov |
| 14 | 1-Jan-2019 | In silico discovery of resveratrol analogues as potential agents in treatment of metabolic disorders | Nebojša Pavlović ; Maja Đanić ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Mladena Lalić-Popović ; Momir Mikov |
| 15 | 2018 | In vivo effects of ursodeoxycholic acid on doxorubicin-induced oxidative injury of hepatocyte | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Svetlana Goločorbin-Kon ; Momir Mikov |
| 16 | 2018 | Non-toxic bile acids as pharmaceutical excipients may alter pharmacological activity of antitumor drug vorinostat | Nebojša Pavlović ; Karmen Stankov ; Svetlana Goločorbin-Kon ; Mladena Lalić-Popović ; Bojan Stanimirov ; Maja Đanić ; Momir Mikov |
| 17 | 1-Feb-2013 | Pharmacogenetic biomarkers as tools for pharmacoepidemiology of severe adverse drug reactions | Stankov, Karmen ; Sabo, Ana ; Mikov, Momir |
| 18 | 1-Jan-2018 | Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome | Maja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
| 19 | 1-Dec-2012 | Pleiotropic functions of bile acids mediated by the farnesoid X receptor | Stanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir |
| 20 | 1-Jun-2018 | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics | Momir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |